Skip to search formSkip to main contentSkip to account menu

Lymphoma

Known as: Lymphoma (Hodgkin's and Non-Hodgkin's), Reticulolymphosarcomas, Lymphomatous 
Cancer that begins in cells of the immune system. There are two basic categories of lymphomas. One kind is Hodgkin lymphoma, which is marked by the… 
National Institutes of Health

Related topics

Related topics

46 relations
ATM protein, humanAtypical lymphocyteB-Cell LymphomasBUB1 gene

Narrower (7)

Immunoblastic Large-Cell LymphomaLymph Node NeoplasmLymphocytic NeoplasmLymphosarcoma Involving Spleen

Broader (2)

Lymphoid organ structureNeoplasms

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2022
Highly Cited
2022
Group
Perhaps I am too concrete, too American in my way of thinking, but I need a level of accessibility that Claudio Neri 's book… 
Review
2014
Review
2014
Cisplatin in cancer therapy: molecular mechanisms of action.
Highly Cited
2013
Highly Cited
2013
Cancer statistics, 2013
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths expected in the United States in the… 
Highly Cited
2007
Highly Cited
2007
Revised response criteria for malignant lymphoma.
PURPOSE Standardized response criteria are needed to interpret and compare clinical trials and for approval of new therapeutic… 
Highly Cited
2002
Highly Cited
2002
CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma
Background The standard treatment for patients with diffuse large-B-cell lymphoma is cyclophosphamide, doxorubicin, vincristine… 
Review
1997
Review
1997
A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project.
The recognition of several new types of non-Hodgkin's lymphoma (NHL) in recent years has led to proposals for changing lymphoma… 
Highly Cited
1996
Highly Cited
1996
NF-κB: Ten Years After
Highly Cited
1993
Highly Cited
1993
A predictive model for aggressive non-Hodgkin's lymphoma.
BACKGROUND Although many patients with intermediate-grade or high-grade (aggressive) non-Hodgkin's lymphoma are cured by… 
Review
1991
Review
1991
p53 mutations in human cancers.
Mutations in the evolutionarily conserved codons of the p53 tumor suppressor gene are common in diverse types of human cancer… 
Highly Cited
1985
Highly Cited
1985
Involvement of the bcl-2 gene in human follicular lymphoma.
Recombinant DNA probes were cloned for the areas flanking the breakpoint on chromosome 18 in cells from a patient with acute… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License